Replies to post #19820 on GOOD TRADERS FORUM

[powerbattles]

HTBX Corporate Milestones
Below we list key milestones for Heat Biologics:

1 - Complete HS-110 Phase II NSCLC enrollment – 2Q:19
2 - HS-130 (ComPACT) IND filing and FDA Clearance – August 2019
3 - HS-110 interim data readout – November 2019
4 - HS-110 Phase II interim readout – 4Q:19
5 - PTX-35 IND clearance and first patient dosing – 2Q:20
6 - Various coronavirus vaccine milestones – 2Q:20
7 - ASCO Poster Presentation – May 29, 2020
8 - Discussion with potential partners – Ongoing
9 - Schedule End of Phase II Meeting with FDA – 2H:20
10 - Complete HS-130 Phase I trial – 4Q:20
11 - Develop Phase III / commercial manufacturing capacity for HS-110 2020